期刊文献+

子宫内膜癌内分泌治疗 被引量:5

Endocrine therapy for endometrial cancer
原文传递
导出
摘要 子宫内膜癌可以用孕激素等进行内分泌治疗,主要用于早期年轻患者保留生育治疗及晚期复发患者姑息治疗。内分泌治疗应有足够的用药时间,并注意观察副反应。目前指南不推荐术后常规应用内分泌治疗。 Endometrial carcinoma can be treated with endocrine therapy (large dose progesterone). It is mainly used in those whose fertility should be preserved and those with advanced stage or recurrence. Whether it can be routinely used in the patients with endometrial cancer is still debated. The endocrine therapy duration shall be enough. And the patients should be followed up closely during the endocrine therapy.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2011年第11期820-823,共4页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 子宫内膜癌 内分泌治疗 GnRH—a endometrial carcinoma endocrine therapy GnRH-a
  • 相关文献

参考文献15

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J]. CA Cancer J Clin ,2011,61 (2) :69-90.
  • 2王志启,王建六,赵丹,高敏,魏丽惠.晚期子宫内膜癌患者预后及其相关因素分析[J].实用妇产科杂志,2007,23(1):39-42. 被引量:7
  • 3Laurelli G,Di Vagno G, Scaffa C,et al. Conservative treatment of early endometrial cancer: preliminary results of a pilot study [ J]. Gynecol Oncol,2011 , 120( 1 ) :43-46.
  • 4Carey MS,Gawlik C, Fung-Kee-Fung M, et al. Systematic review of systemic therapy for advanced or recurrent endometrial cancer[ J]. Gynecol Oncol,2006,101 ( 1 ) : 158-167.
  • 5Vishnevsky AS,Bokhman YaV, Loutfi G. Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen on 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients [ J ]. Eur J Gynaecol Oncol, 1993,14 : 150-153.
  • 6Paulssen RH, Moe B, Grnaas H, et al. Gene expression in endometrial cancer cells (lshikawa) after short time high dose exposure to progesterone[ J]. Steroids,2008,73( 1 ) :116-128.
  • 7Kresowik J, Ryan GL, van Voorhis BJ. Progression of atypical endometrial hyperplasia to adenocarcinoma despite intrauterine progesterone treatment with the levonorgestrel-releasing intrauterine system [ J ]. Obstet Gynecol,2008,111 ( 2 Pt 2 ) :547-549.
  • 8Covens AL,Filiaci V, Gersell D, et al. Phase II study of fulvestrant in recurrent/metastatic endometrial carcinoma: a Gynecologic Oncology Group study [ J ]. Gynecol Oncol,2011 , 120 ( 2 ) :185-188.
  • 9Kaibara M,Watanabe T, Ooka F, et al. Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer[ J]. Clin Hemorheol Microcirc,2001,24 :93-99.
  • 10von Minckwitz G, Loibl S, Brunnert K, et al. Adjuvant endocrine treatment with medroxyprogesterone acetate or tamoxifen in stage I and II endometrial cancer-a multicentre, open, controlled, prospectively randomised trial [ J ]. Eur J Cancer, 2002,38 : 2265 -2271.

二级参考文献18

  • 1李斌,吴令英,李淑敏,章文华,张蓉,马绍康.子宫内膜癌的预后影响因素分析[J].癌症,2004,23(9):1085-1088. 被引量:31
  • 2王志启,王建六,郭健,魏丽惠.内分泌辅助治疗子宫内膜癌的临床意义[J].中华医学杂志,2005,85(34):2414-2419. 被引量:21
  • 3Thigpen JT,Brady MF,Alvarez RD,et al.Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma:a dose-response study by the Gynecologic Oncology Group[J].J Clin Oncol,1999,17(6):1736-1744.
  • 4Imai M,Jobo T,Sato R,et al.Medroxyprogesterone acetate therapy for patients with adenocarcinoma of the endometrium who wish to preserve the uterus-usefulness and limitations[J].Eur J Gynaecol Oncol,2001,22(3):217-220.
  • 5Kinster RW.Histological effects of progestins on hyperplasia and carcinoma in situ of the endometrium[J].Cancer,1959,12:1106-1122.
  • 6Kauppila A,Gronroos M,Nieminen U.Clinical outcome in endometrial cancer[J].Obstet Gynecol,1982,60(4):473-480.
  • 7Lewis GC,Slack NH,Mortel R,et al.Adjuvant progestogen therapy in the primary definitive treatment of endometrial cancer[J].Gynecol Oncol,1974,2(2-3):368-376.
  • 8Vergote I,Kjorstad K,Abeler V,et al.A randomized trial of adjuvant progestagen in early endometrial cancer[J].Cancer,1989,64(5):1011-1016.
  • 9De Palo G,Mangioni C,Periti P,et al.Treatment of FIGO (1971) stage I endometrial carcinoma with intensive surgery,radiotherapy and hormonotherapy according to pathological prognostic groups:long-term results of a randomized multicentre study[J].Eur J Cancer,1993,29A(8):1133-1140.
  • 10Vishnersky AS,Bokhman YV,Loutfi G.Favourable influence of adjuvant hormone therapy by oxyprogesterone caproate (OPC) and by its combination with tamoxifen of 5-year survival rate of surgical and combined treatment of primary endometrial carcinoma patients[J].Eur J Gynaecol Oncol,1993,14(2):150-153.

共引文献11

同被引文献38

  • 1王志启,王建六,郭健,魏丽惠.内分泌辅助治疗子宫内膜癌的临床意义[J].中华医学杂志,2005,85(34):2414-2419. 被引量:21
  • 2王志启,王建六,魏丽惠.辅助内分泌治疗对Ⅰ期子宫内膜癌疗效的临床观察[J].中国实用妇科与产科杂志,2006,22(11):824-827. 被引量:8
  • 3王志启,王建六,赵丹,高敏,魏丽惠.晚期子宫内膜癌患者预后及其相关因素分析[J].实用妇产科杂志,2007,23(1):39-42. 被引量:7
  • 4张玉泉.子宫内膜癌的内分泌治疗现状[J].现代妇产科进展,1997,6(2):176-179. 被引量:2
  • 5Siegel R, Naishadham D,J ernal A Cancer statistics, 2013. CA CancerJ Clin, 2013, 63: 11 - 30.
  • 6Lee CM, Szabo A, Shrieve DC, et al. Frequency and effect of adjuvant radiation therapy among women with stage I en?dometrial adenocarcinoma.JAMA, 2006, 295: 389-397.
  • 7Niwa K, Tagami K, Lian Z, et al. Outcome of fertility - pre?serving treatment in young women with endometrial carcino?mas. BJOG. 2005,112: 317-320.
  • 8Mohan DS. Samuels MA, Selim MA, et al. Long - term out?comes of therapeutic pelvic lymphadenectomy for stage I endome?trial adenocarcinoma GynecolOncol, 1998, 70: 165 -171.
  • 9Podratz KC, Mariani A. Webb MJ. Staging and therapeutic value of lymphadenectomy in endometrial cancer. Gynecol Oncol , 1998, 70: 163 -164.
  • 10McMeekin DS, Lashbrook D, Gold M, et al. Analysis of FI?GO Stage HIe endometrial cancer patients. Gynecol Oncol , 2001, 81: 273 - 278.

引证文献5

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部